2024 annual financial data
CytoMed Therapeutics 2024 Net margin
Direct answer
Net margin was -3,621.1%.
Operating income was -3,130,528 SGD and net income was -2,516,698 SGD.
Operating cash flow was -2,709,331 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 69,501 SGD
- Operating income
- -3,130,528 SGD
- Net income
- -2,516,698 SGD
- Operating cash flow
- -2,709,331 SGD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all CytoMed Therapeutics financial years